Model
Edge
Lineage Cell Therapeutics
0001310683
Filing Type
4
Filing Date
3/7/2024
Updated
3/8/24, 9:05 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership